Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 48,040,952
  • Shares Outstanding, K 1,431,921
  • Annual Sales, $ 10,735 M
  • Annual Income, $ 4,700 M
  • 60-Month Beta 0.98
  • Price/Sales 4.51
  • Price/Cash Flow 14.06
  • Price/Book 3.07
Trade BSX with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 0.34
  • Number of Estimates 11
  • High Estimate 0.39
  • Low Estimate 0.28
  • Prior Year 0.46
  • Growth Rate Est. (year over year) -26.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.99 +1.70%
on 11/23/20
39.50 -15.06%
on 11/09/20
-3.62 (-9.74%)
since 10/23/20
3-Month
32.99 +1.70%
on 11/23/20
42.37 -20.82%
on 09/03/20
-6.09 (-15.36%)
since 08/25/20
52-Week
24.10 +39.21%
on 03/23/20
46.62 -28.04%
on 12/20/19
-9.30 (-21.70%)
since 11/25/19

Most Recent Stories

More News
Minimally Invasive & Non-Invasive Medical Imaging Market to Touch USD 88.88 Billion by 2027; High Demand for Real Time Image Processing with High-Quality Images for Efficient Results to Create Opportunities for Market Growth Over 2020-2027

The number of robotic surgeries skyrocketed in the last decade. With the success rate ranging between 90-100%, a significant increase in the minimally invasive surgeries (MIS) demonstrating improved outcomes...

BSX : 33.55 (-0.71%)
CNMD : 104.44 (-2.14%)
MDT : 113.31 (-0.66%)
OCPNY : 20.5900 (-1.15%)
SIEGY : 67.3350 (+0.64%)
Global Cardiovascular Devices Market to Rise at 6.4% CAGR and Reach USD 82.20 Billion by 2026; Rising Awareness and Increasing Demand for Cardiovascular Surgical Devices Will Promote Market Growth, says Fortune Business Insights(TM)

According to the report, the cardiovascular devices market size was USD 49.90 billion in 2018 and is projected to rise at a CAGR of 6.4% between 2019 and 2026. The global market size is prognosticated...

BSX : 33.55 (-0.71%)
CSII : 35.29 (-0.42%)
EW : 84.21 (-1.64%)
GE : 10.50 (+0.48%)
LIVN : 53.57 (+0.43%)
SIEGY : 67.3350 (+0.64%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSX

Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX). Such investors are advised to contact Robert S. Willoughby...

BSX : 33.55 (-0.71%)
Heart Valve Repair and Replacement Market Share | Growth, Opportunities, Industry Applications, Analysis and Forecast To 2025

AORTF : 4.6730 (+3.33%)
BSX : 33.55 (-0.71%)
CRY : 21.09 (-2.41%)
LIFE : 3.59 (+2.28%)
MDT : 113.31 (-0.66%)
NVCN.TO : 1.09 (+1.87%)
STJ : 80.82 (+0.16%)
Boston Scientific to Participate in Evercore ISI 2020 Healthcare Conference

, /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2020 Evercore ISI HealthCONx Conference on .

BSX : 33.55 (-0.71%)
Penile Implant Market to reach US $898.4 million by 2028 - Global Insights on Key Trends, Competitive Landscape, COVID-19 Impact Analysis, Growth Drivers and Future Outlook: Adroit Market Research

The "Global Penile Implant Market Size 2020, By Type (Inflatable penile implant, Non-inflatable/malleable penile implant) By End Use (Hospitals, Ambulatory Surgery Center, Others) Region (North America,...

BSX : 33.55 (-0.71%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSX

Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX). Such investors are advised to contact Robert S. Willoughby...

BSX : 33.55 (-0.71%)
Investor Alert: Kaplan Fox Continues To Investigate Boston Scientific Corporation (BSX)

, /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP () has been  investigating potential claims against Boston Scientific Corporation (NYSE: BSX) ("BSX" or the "Company") for violations of the federal securities...

BSX : 33.55 (-0.71%)
The Worldwide Spinal Implants Industry is Projected to Reach $17.4 Billion by 2026

, /PRNewswire/ -- The report has been added to offering.

ABT : 106.41 (-1.12%)
BSX : 33.55 (-0.71%)
CFX : 37.95 (+0.88%)
MDT : 113.31 (-0.66%)
NUVA : 47.56 (-0.98%)
OFIX : 38.14 (-1.37%)
SPNE : 14.31 (+1.63%)
SYK : 233.72 (-2.74%)
ZBH : 149.68 (-0.93%)
Insights on the Gynecological Devices Industry in the EU% to 2025 - Featuring Hologic, Boston Scientific and Medtronic Among Others

The "EU5 Gynecological Devices Market Outlook to 2025 - Endometrial Ablation Devices and Female Sterilization Devices" report has been added to ResearchAndMarkets.com's offering.

BSX : 33.55 (-0.71%)
HOLX : 68.23 (+0.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce...

See More

Key Turning Points

2nd Resistance Point 34.17
1st Resistance Point 33.86
Last Price 33.55
1st Support Level 33.37
2nd Support Level 33.19

See More

52-Week High 46.62
Fibonacci 61.8% 38.02
Fibonacci 50% 35.36
Last Price 33.55
Fibonacci 38.2% 32.70
52-Week Low 24.10

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar